VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_17-vv-01099 Package ID: USCOURTS-cofc-1_17-vv-01099 Petitioner: Stephen Kaiser Filed: 2017-08-15 Decided: 2020-01-09 Vaccine: influenza Vaccination date: 2015-10-29 Condition: Guillain-Barré Syndrome Outcome: compensated Award amount USD: 30000 AI-assisted case summary: On August 15, 2017, Stephen Kaiser filed a petition for compensation under the National Vaccine Injury Program, alleging that he developed Guillain-Barré Syndrome (GBS) as a result of receiving an influenza vaccine on October 29, 2015. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused petitioner's alleged injuries. The parties reached a stipulation for an award, agreeing that the issues between them would be settled. The stipulation provided for a lump sum payment of $30,000.00, payable to the petitioner, to compensate for pain and suffering, past unreimbursable expenses, and past lost earnings. Special Master Thomas L. Gowen adopted the stipulation and awarded compensation accordingly. The decision was filed on January 9, 2020. Petitioner was represented by John R. Howie, Jr. of Howie Law, PC, and respondent was represented by Sarah C. Duncan of the U.S. Dept. of Justice. The public decision does not describe the specific onset of symptoms, medical tests, treatments, or the mechanism of causation. Theory of causation field: Petitioner Stephen Kaiser received an influenza vaccine on October 29, 2015, and alleged that this vaccination caused him to develop Guillain-Barré Syndrome (GBS). Respondent denied causation. The parties entered into a stipulation for award, agreeing to settle the issues. The stipulation provided for a lump sum payment of $30,000.00 to compensate for pain and suffering, past unreimbursable expenses, and past lost earnings. Special Master Thomas L. Gowen adopted the stipulation and awarded compensation on January 9, 2020. The public decision does not detail the specific theory of causation, medical experts, or the mechanism by which the vaccine allegedly caused GBS. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_17-vv-01099-0 Date issued/filed: 2020-02-14 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 01/09/2020) regarding 52 DECISION Stipulation/Proffer Signed by Special Master Thomas L. Gowen. (hs) Service on parties made. -------------------------------------------------------------------------------- Case 1:17-vv-01099-UNJ Document 59 Filed 02/14/20 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: January 9, 2020 * * * * * * * * * * * * * STEPHEN KAISER, * Unpublished * Petitioner, * No. 17-1099V * v. * Special Master Gowen * SECRETARY OF HEALTH * Stipulation for Award; Influenza AND HUMAN SERVICES, * (“flu”) Vaccine; Guillain-Barré * Syndrome (“GBS”). Respondent. * * * * * * * * * * * * * * John R. Howie, Jr., Howie Law, PC, Dallas, TX, for petitioner. Sarah C. Duncan, U.S. Dept. of Justice, Washington, D.C., for respondent. DECISION FOR STIPULATION1 On August 15, 2017, Stephen Kaiser (“petitioner”), filed a petition for compensation under the National Vaccine Injury Program.2 Petition (ECF No. 1). Petitioner received an influenza (“flu”) vaccine on October 29, 2015. Petition at Preamble; Stipulation at ¶ 2 (ECF No. 51). Petitioner alleged that as a result of receiving the flu vaccination, he suffered Guillain-Barré Syndrome (“GBS”). Petition at Preamble; Stipulation at ¶ 4. On January 9, 2020, respondent filed a stipulation providing that a decision should be entered awarding compensation to petitioner. Stipulation at ¶ 7. Respondent denies that the flu vaccine is the cause of petitioner’s alleged injuries, or any other injury or his current condition. Id. at ¶ 6. Nevertheless, maintaining their respective positions, the parties now agree that the issues between them shall be settled and that a decision should be entered awarding the 1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this opinion contains a reasoned explanation for the action in this case, I am required to post it on the website of the United States Court of Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. This means the opinion will be available to anyone with access to the Internet. Before the opinion is posted on the court’s website, each party has 14 days to file a motion requesting redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). “An objecting party must provide the court with a proposed redacted version of the decision.” Id. If neither party files a motion for redaction within 14 days, the opinion will be posted on the court’s website without any changes. Id. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012) (Vaccine Act or the Act). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. Case 1:17-vv-01099-UNJ Document 59 Filed 02/14/20 Page 2 of 7 compensation to petitioner according to the terms of the stipulation attached hereto as Appendix A. Id. at ¶ 7. The stipulation provides: 1) A lump sum of $30,000.00, which amount represents compensation for pain and suffering, past unreimbursable expenses, and past lost earnings, in the form of a check payable to the petitioner. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). I adopt the parties’ stipulation attached hereto, and award compensation in the amount and on the terms set forth therein. The Clerk of the Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED. s/Thomas L. Gowen Thomas L. Gowen Special Master 3 Entry of judgment is expediated by each party’s filing notice renouncing the right to seek review. Vaccine Rule 11(a). 2 Case 1:17-vv-01099-UNJ Document 59 Filed 02/14/20 Page 3 of 7 Case 1:17-vv-01099-UNJ Document 59 Filed 02/14/20 Page 4 of 7 Case 1:17-vv-01099-UNJ Document 59 Filed 02/14/20 Page 5 of 7 Case 1:17-vv-01099-UNJ Document 59 Filed 02/14/20 Page 6 of 7 Case 1:17-vv-01099-UNJ Document 59 Filed 02/14/20 Page 7 of 7